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observed after coarctation repair is not a new
phenomenon, but is simply the continuation
of the neurosympathetic process that existed
before the coarctation repair.
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Carolinas Medical Center
Charlotte, NC 28203
Reference
1. Hager A, Kanz S, Kaemmerer H, Schreiber C,
Hess J. Coarctation Long-term Assessment
(COALA): significance of arterial hyperten-
sion in a cohort of 404 patients up to 27 years
after surgical repair of isolated coarctation of
the aorta, even in the absence of restenosis
and prosthetic material. J Thorac Cardiovasc
Surg. 2007;134:738-45.
doi:10.1016/j.jtcvs.2007.11.053
Heart valve tissue engineering:
Research should proceed along
validated routes
To the Editor:
In their article focusing on in vivo autolo-
gous recellularization of a tissue-engineered
heart valve, Vincentelli and colleagues1
raise 2 main questions: (1) Which are the
best candidates for scaffold repopulation?
(2) Does direct injection of cells into the
scaffold guarantee adequate cellular recolo-
nization?
According to the cell type chosen for
scaffold seeding, the adoption of nonse-
lected bone marrow–derived mononuclear
cells was associated with early degeneration
with thickening and retraction of the cusps,
growth of fibrotic pannus along the suture
lines, and thickening and calcification of
the wall conduits. Histologically, a marked
inflammatory response with extracellular
matrix disarray and macrophage infiltration
both in the adventitia and the media layers
were observed, along with a loss of the
proper collagen allocation between the
ventricularis, spongiosa, and fibrosa of the
leaflets. Additionally, a significant increase
of both transvalvular and distal gradients
were recorded at 4-month follow-up echo-
cardiographic analysis. On the contrary,
scaffolds repopulated with mesenchymal
stem cells did not evidence either degenera-
tive notes or inflammatory reactions.
These findings might suggest ‘‘the onset
of a structural deterioration of the scaffold in
the [bone marrow–derived mononuclear
cell] group and a protective effect of the
injections of [mesenchymal stem cells].’’1
We are concerned that such conclusions
seem audacious because the study suffers
from a main limitation represented by the
cell-seeding modality. In fact, the authors,
looking for an answer to question number
2, choose to inject the cells directly into
the decellularized scaffold (onto the conduit
walls and valve annulus, excluding the
leaflets), instead of adopting a biomimetic
environment.
The adoption of this alternative tech-
nique,which has been derived from themyo-
cardial setting,2 represents an innovative
concept for the valvular field and therefore
requires a careful validation. Fluorescent
cell tracking, which was performed on 4 of
14 animals in the first postoperative week,
evidenced, on day 1, the cell persistence
onto the injection site and, on day 7, a few
scattered cells into the matrix, the arterial
wall, and the leaflets. Moreover, nonlabeled
cells of host origin were found.
Is this enough to say that ‘‘in situ injec-
tion of bone marrow cells into a porcine
decellularized scaffold before implantation
enhanced the in vivo recolonization and
induced full re-endothelization’’?1 First,
endothelialization and scaffold repopulation
do not coincide. Even bioprostheses un-
dergo an endothelialization process of the
inert components once implanted. Second,
the process of repopulation implies an
architectural and hierarchic cell-specific
distribution along the leaflet’s ventricularis,
spongiosa, and fibrosa,3 which was not
observed in this experience.
In the article’s ‘‘Discussion’’ section, the
authors themselves affirm that they had no
direct evidence that cells would grow inside
the matrix. According to the hypothesis that
injected cells might enhance autologous
recellularization, further evidence is needed
to draw definite conclusions, and the pro-
vided results do not concretely support the
initial hypothesis.
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Robicsek outlined in his letter to the Editor
in response to our article1 that arterial hyper-
tension exists distal the coarctation even
before coarctation repair. Hypertension in
the long-term follow-up is simply the con-
tinuation of this neurosympathetic process.
Previously published data from our
group2 on blood pressure and aortic disten-
sibility in neonates with coarctation before
and after surgical repair did not show
poststenotic hypertension before repair in
general. However, we totally agree with
Robicsek and other authors3,4 that inborn
processes not touched by current modes of
repair are also responsible for hypertension
in the long-term follow-up after successful
repair. We believe that the starting point of
the pathophysiologic chain is the inborn
alteration of the arterial wall with elastic fi-
ber fragmentation, fibrosis, and cystic me-
dial necrosis, which are later exaggerated
by existing hypertension. This causes the in-
creased stiffness most pronounced in the
central elastic arteries, the blunted barore-
ceptor reflex, and the neurosympathetic acti-
vation. However, the novelty of our study
was the extent of this phenomenon. Our
relation to age showed that arterial hyperten-
sion has to be expected in almost all patients
after coarctation repair in older ages. Close
surveillance and aggressive treatment of
arterial hypertension might prevent further
cardiovascular disease.
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